Purchases and Sales Made in Q2 2024 in Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN) during Q2 2024. The information is specifically focused on institutions that hold shares of Terns Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-52.9K- 21.29% |
$240K - $433K
|
195K
$1.12M
|
|
|
Aug 14, 2024
Q2 2024
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-95.8K- 20.6% |
$435K - $786K
|
369K
$2.12M
|
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-160K- 86.03% |
$727K - $1.31M
|
26K
$149K
|
|
|
Aug 14, 2024
Q2 2024
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-161K- 12.26% |
$729K - $1.32M
|
1.15M
$6.59M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-253K- 43.15% |
$1.15M - $2.08M
|
334K
$1.91M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-253K- 43.15% |
$1.15M - $2.08M
|
334K
$1.91M
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-269K- 63.69% |
$1.22M - $2.2M
|
153K
$877K
|
|
|
Jun 12, 2025
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-288K- 74.79% |
$1.31M - $2.36M
|
97.2K
$557K
|
|
|
Aug 14, 2024
Q2 2024
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-475K- 7.13% |
$2.16M - $3.89M
|
6.18M
$35.4M
|
|
|
Aug 14, 2024
Q2 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-1.26M- 52.86% |
$5.72M - $10.3M
|
1.12M
$6.43M
|
|
|
Aug 14, 2024
Q2 2024
|
Fairmount Funds Management LLC
Philadelphia, PA |
SELL
|
- |
-1.29M- 63.28% |
$5.86M - $10.6M
|
749K
$4.29M
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.51M- 50.77% |
$6.84M - $12.3M
|
1.46M
$8.37M
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-2.29M- 66.78% |
$10.4M - $18.8M
|
1.14M
$6.53M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.01M- 90.03% |
$13.7M - $24.7M
|
334K
$1.91M
|